Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (571-580 of 818) with videos related to

Pageof 82
Sort By:
Journal of Chemotherapy (Florence, Italy)|December 3, 2010
Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infectionsM A Pfaller, P R Rhomberg, H S Sader, et al.
Diagnostic Microbiology and Infectious Disease|June 23, 1998
Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and CanadaR N Jones, C H Ballow, D J Biedenbach, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 1998
In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysisR N Jones, C H Ballow, J J Schentag, et al.
Diagnostic Microbiology and Infectious Disease|April 29, 1998
National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of EpidemiologicM A Pfaller, R N Jones, S A Messer, et al.
Diagnostic Microbiology and Infectious Disease|December 24, 1997
Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymesR N Jones, M A Pfaller, S A Marshall, et al.
Diagnostic Microbiology and Infectious Disease|January 8, 2000
Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridoneR N Jones, M E Erwin, D J Biedenbach, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC resultsD J Biedenbach, R N Jones, M T Lewis, et al.
Statistics in Medicine|January 1, 1984
An application of kappa-type analyses to interobserver variation in classifying chest radiographs for pneumoconiosisD C Musch, J R Landis, I T Higgins, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella speciesD M Johnson, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporinB M Briggs, R N Jones, M E Erwin, et al.
Pageof 82

Showing results (571-580 of 818) with videos related to

Sort By:
Pageof 82
Journal of Chemotherapy (Florence, Italy)|December 3, 2010
Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infectionsM A Pfaller, P R Rhomberg, H S Sader, et al.
Diagnostic Microbiology and Infectious Disease|June 23, 1998
Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and CanadaR N Jones, C H Ballow, D J Biedenbach, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 1998
In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysisR N Jones, C H Ballow, J J Schentag, et al.
Diagnostic Microbiology and Infectious Disease|April 29, 1998
National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of EpidemiologicM A Pfaller, R N Jones, S A Messer, et al.
Diagnostic Microbiology and Infectious Disease|December 24, 1997
Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymesR N Jones, M A Pfaller, S A Marshall, et al.
Diagnostic Microbiology and Infectious Disease|January 8, 2000
Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridoneR N Jones, M E Erwin, D J Biedenbach, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC resultsD J Biedenbach, R N Jones, M T Lewis, et al.
Statistics in Medicine|January 1, 1984
An application of kappa-type analyses to interobserver variation in classifying chest radiographs for pneumoconiosisD C Musch, J R Landis, I T Higgins, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella speciesD M Johnson, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporinB M Briggs, R N Jones, M E Erwin, et al.
Pageof 82